Showing results (1551-1560 of 1,605) with videos related to

Sort By:
Pageof 161
The Oncologist|November 4, 2020
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA-Mutated Metastatic Castrate-Resistant Prostate CancerMitchell S Anscher, Elaine Chang, Xin Gao, et al.
NEJM Evidence|July 22, 2025
Contraceptive Efficacy and Comparative Side Effects of a Mini Copper Intrauterine DeviceCourtney A Schreiber, Kavita Nanda, David Hubacher, et al.
JTO Clinical and Research Reports|April 27, 2026
Durvalumab Plus Chemotherapy in Patients With <i>EGFR</i>-Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARDByoung Chul Cho, Makoto Nishio, Myung-Ju Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
Osimertinib Plus Gefitinib in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer and EGFR (C797X) Mutation Following First-Line Osimertinib: ORCHARDSarah B Goldberg, Myung-Ju Ahn, Christina Baik, et al.
Genome Medicine|July 12, 2023
Metagenomic assessment of gut microbial communities and risk of severe COVID-19Long H Nguyen, Daniel Okin, David A Drew, et al.
Research Square|August 17, 2021
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine releaseCaroline Junqueira, Ângela Crespo, Shahin Ranjbar, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Duration of viable virus shedding in SARS-CoV-2 omicron variant infectionJulie Boucau, Caitlin Marino, James Regan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2021
FDA Approval Summary: Selumetinib for Plexiform NeurofibromaDenise Casey, Suzanne Demko, Arup Sinha, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine releaseCaroline Junqueira, Ângela Crespo, Shahin Ranjbar, et al.
Cancer Research|March 21, 2020
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance <i>EGFR</i> MutationsJacqueline H Starrett, Alexis A Guernet, Maria Emanuela Cuomo, et al.
Pageof 161